SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 96 filers reported holding CARDIFF ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q2 2021$326,000
-9.4%
49,035
+26.0%
0.01%0.0%
Q1 2021$360,000
-55.7%
38,912
-13.7%
0.01%
-60.0%
Q4 2020$812,000
+47.1%
45,112
+15.9%
0.02%
-6.2%
Q3 2020$552,00038,9120.02%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
CAXTON CORP 2,522,083$15,158,00012.39%
Octagon Capital Advisors LP 982,753$5,906,0001.15%
Altium Capital Management LP 337,000$2,025,0000.56%
ACT CAPITAL MANAGEMENT, LLC 102,500$616,0000.44%
Eventide Asset Management 1,670,399$10,039,0000.13%
Artal Group S.A. 750,000$4,508,0000.12%
Aquatic Capital Management LLC 8,000$48,0000.09%
ELKHORN PARTNERS LIMITED PARTNERSHIP 17,300$104,0000.06%
Anson Funds Management LP 69,381$417,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 170,447$1,024,0000.02%
View complete list of CARDIFF ONCOLOGY INC shareholders